Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 607-240-0 | CAS number: 23511-73-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25 Oct - 01 Dec 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 428 (Skin Absorption: In Vitro Method)
- Version / remarks:
- adopted Apr 2004
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, München, Germany
Test material
- Reference substance name:
- 2-phenoxyethyl octanoate
- EC Number:
- 607-240-0
- Cas Number:
- 23511-73-1
- Molecular formula:
- C16H24O3
- IUPAC Name:
- 2-phenoxyethyl octanoate
Constituent 1
- Radiolabelling:
- yes
Administration / exposure
- Details on in vitro test system (if applicable):
- SKIN PREPARATION
- Source of skin: Skin membranes of female human abdominal origin sourced from cosmetic surgery were used. Due to inter-individual variability skin from 4 different donors was used.
- Skin samples are either purchased from Biopredic International, France or prepared at Eurofins Munich in house (skin obtained from Hepacult/HTCR).
- Type of skin: Human abdominal skin without stretch marks, hair, moles or birthmarks. The dermatomed skin discs (200 to 400/500 µm) comprising the stratum corneum, the epidermis and part of the dermis showed a diameter of 16 mm.
- Thickness of skin (in mm): undiluted test substance: 0.385 - 0.458; diluted test substance: 0.356 - 0.442
- Membrane integrity check: After visual check of the skin membrane, the skin in the assembled diffusion cells was checked for barrier integrity using tritiated water. Therefore, after equilibration of the skin membranes for approximately 15 min, 40 µL of tritiated water (1 kBq) were applied to the skin surface for 20 min. The receptor fluid flow was regulated to deliver about 0.2 mL/h. The unabsorbed material was then blotted with a cotton-tipped applicator and 40 µL PBS was applied to the skin surface. Effluent from the flow cell was collected for an additional 60 min. Skin was regarded as being undamaged if not more than 2% of the applied radioactivity was recovered from the receptor fluid.
- Storage conditions: ≤ -15 °C
PRINCIPLES OF ASSAY
- Diffusion cell: The diffusion cell is designed with a PTFE-donator and -acceptor part of the flow through diffusion cell for horizontal exposure of the skin surface.
- Receptor fluid: 50% ethanol
- Flow-through system: The diffusion cells were set in a microprocessor controlled thermostatisation block. A multi-channel peristaltic pump was connected with the receptor part of the diffusion cell and a programmable fraction collector was responsible for collecting the samples. The receptor fluid flow was regulated to deliver about 0.2 mL/h.
- Test temperature: undiluted test substance: 31.1 - 33.5 °C (8 h) and 31.4 - 33.1 °C (24 h); diluted test substance: 32.3 - 33.8 °C (8 h) and 31.9 - 33.6 °C (24 h)
- Other: 10 µL/cm² were applied onto the skin surface (0.78 mm²), depending on the physical state of the test formulation (solid/liquid). Two different concentrations of the test item were tested. For each concentration - undiluted and diluted concentration - of the formulation 10 replicates were set up. After an exposure period of 8 h the test item was washed off with a cleansing agent (1% aqueous soap solution, “Reine Pflanzenöl Kernseife”, Haslinger Seifen & Kosmetik GmbH, Charge: 2981). Residual test item was wiped from the donor side of the diffusion cell and the skin surface with a cotton bud. Additionally various rinsing steps with receptor fluid were performed to remove the remaining test item. The cotton buds and the rinsing liquid were stored at ≤ -15°C for further analysis of the remaining test item. After a 24 h period the experiment will be terminated. Sampling times of receptor fluid were 1, 2, 4, 8, 12, 16 and 24 h. The receptor fluid flow was regulated to deliver about 0.2 mL/h. The skin discs were removed from the chambers and stripping of the upper skin layers was performed. Skin was stripped with 15 pieces of adhesive tape, whereas groups of the sequential layers will be pooled. Tape stripping was terminated, if there was evidence that the stratum corneum had been completely removed. Up to 100 µL of each fraction of the receptor fluid were mixed with 2 mL scintillation cocktail (UltimaGoldTM, Perkin Elmer). The quantitatively collected residual test item (cotton buds) was supplemented with 10 mL scintillation cocktail and incubated in a water bath at 50 °C for about 60 minutes. The exposed skin discs and strips were incubated with 4 mL or 3 mL SolvableTM (Perkin Elmer), respectively over night at 50°C. After lysis of the skin and cooling down to room temperature, 100 µL of this extract were added to 2 mL of the scintillation cocktail.
The amount of test item in the receptor fluid, the quantitatively collected residual, non penetrated test item (skin wash), the skin and the strips were analyzed using a β-counter (Tricarb, Perkin Elmer).
Results and discussion
- Absorption in different matrices:
- - Receptor fluid (in vitro test system): In the receptor fluid mean values of 0.28% (SD: 0.31%) of the undiluted test item and 3.67% (SD: 3.52%) of the 10% test item formulation were detected.
- Skin preparation (in vitro test system): In the skin mean values of 3.06% (SD: 0.84%) of the undiluted test item and 9.78% (SD: 4.79%) of the 10% test item formulation were detected. - Total recovery:
- - Total recovery: Mean recovery rates were 100.26% and 95.11% for the undiluted and the 10% formulation of the test item, respectively.
Percutaneous absorptionopen allclose all
- Key result
- Time point:
- 24 h
- Dose:
- 10 µL/cm²
- Parameter:
- amount
- Remarks:
- mean
- Absorption:
- 6.78 %
- Remarks on result:
- other: undiluted test item
- Key result
- Time point:
- 24 h
- Dose:
- 10 µL/cm²
- Parameter:
- amount
- Remarks:
- mean
- Absorption:
- 18.85 %
- Remarks on result:
- other: 10% test item solution in (in Basic Formulation W/O Lotion mit Tegosoft XC+DEC)
Any other information on results incl. tables
Table 1: Results (undiluted)
|
1 |
2 |
3 |
4d |
5 |
6d |
7 |
8 |
9d |
10 |
Meane |
SD |
Skin Wash 8h |
77.38 |
81.63 |
85.27 |
77.52 |
79.87 |
78.10 |
77.40 |
87.77 |
64.87 |
82.00 |
81.62 |
3.88 |
Skin Wash 24 h |
3.04 |
3.86 |
2.55 |
1.06 |
1.98 |
1.19 |
4.52 |
2.16 |
11.66 |
2.06 |
2.88 |
0.98 |
Chamber wash lid |
0.23 |
0.70 |
0.54 |
0.43 |
0.13 |
0.29 |
0.66 |
0.30 |
0.71 |
0.36 |
0.42 |
0.22 |
Strips 1-2 |
8.18 |
4.68 |
5.89 |
7.41 |
4.98 |
4.05 |
8.68 |
3.69 |
14.94 |
7.27 |
6.20 |
1.89 |
Strips 3 - ∞ |
7.66 |
5.90 |
2.64 |
6.91 |
7.08 |
4.20 |
5.34 |
3.53 |
4.15 |
4.71 |
5.27 |
1.81 |
Skin |
3.17 |
2.76 |
2.26 |
5.65 |
4.67 |
11.12 |
3.09 |
2.15 |
1.83 |
3.31 |
3.06 |
0.84 |
Receptor Fluid (RF) |
0.08 |
0.22 |
0.43 |
0.67 |
0.90 |
0.29 |
0.15 |
0.07 |
1.71 |
0.08 |
0.28 |
0.31 |
Gauze |
0.23 |
0.22 |
0.37 |
0.27 |
0.28 |
0.69 |
0.12 |
0.23 |
0.08 |
0.19 |
0.24 |
0.08 |
Chamber wash RF |
0.04 |
0.03 |
0.05 |
0.07 |
0.09 |
0.07 |
0.03 |
0.10 |
0.06 |
0.03 |
0.05 |
0.03 |
Total |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Absorption [%]a |
11.18b |
3.24 |
5.75b |
6.66 |
13.03b |
16.37 |
3.39 |
2.55 |
7.82 |
8.31b |
6.78c |
4.16 |
Recovery [%] normalized on applied dose |
100.49 |
96.49 |
99.52 |
98.63 |
102.14 |
99.48 |
100.39 |
103.56 |
94.92 |
99.21 |
100.26 |
2.25 |
% of total absorption at 12h |
70.64 |
85.15 |
59.55 |
96.49 |
8.98 |
5.56 |
92.31 |
77.83 |
45.64 |
69.30 |
66.25 |
27.46 |
In the total absorption (a) the amount of test item of skin, receptor fluid, gauze and chamber wash RF is included. In case of chamber 1, 3, 5 and 10 the strips 3 - ∞ were included in the calculation of the total absorption (b). The mean value for total absorption (c) is calculated of the total absorption values of the single replicates. Replicates 4, 6 and 9 were excluded for evaluation of results (d). Mean is calculated from skin replicates1, 2, 3, 5, 7, 8 and 10(e).
Replicates 4 and 6 were excluded for evaluation of results due to a lack of receptor fluid. Replicates 9 was excludedbecause the recovery rates was outside the range of 100% ± 10%.
Table 2: Results (10% formulation)
|
1d |
2d |
3 |
4d |
5d |
6 |
7 |
8 |
9 |
10 |
Meane |
SD |
Skin Wash 8h |
64.59 |
77.43 |
75.66 |
56.44 |
46.66 |
64.74 |
61.14 |
58.50 |
63.09 |
70.28 |
65.57 |
6.33 |
Skin Wash 24 h |
4.85 |
1.49 |
3.20 |
4.46 |
5.52 |
4.33 |
5.98 |
4.15 |
4.06 |
5.55 |
4.54 |
1.03 |
Chamber wash lid |
0.48 |
0.24 |
0.27 |
0.72 |
0.18 |
0.27 |
0.28 |
0.21 |
0.25 |
0.20 |
0.25 |
0.04 |
Cotton |
0.61 |
0.64 |
0.65 |
0.62 |
0.69 |
0.64 |
0.67 |
0.62 |
0.59 |
0.66 |
0.64 |
0.03 |
Strips 1-2 |
3.32 |
2.16 |
3.99 |
5.14 |
7.63 |
7.41 |
8.93 |
10.23 |
7.18 |
4.06 |
6.97 |
2.53 |
Strips 3 - ∞ |
10.08 |
4.30 |
4.57 |
9.73 |
14.92 |
8.15 |
6.82 |
9.32 |
9.76 |
5.31 |
7.32 |
2.12 |
Skin |
5.87 |
12.58 |
3.27 |
12.43 |
9.58 |
12.98 |
14.41 |
12.87 |
10.83 |
4.30 |
9.78 |
4.79 |
Receptor Fluid (RF) |
6.45 |
0.24 |
7.11 |
7.67 |
13.93 |
0.22 |
0.21 |
2.64 |
3.17 |
8.66 |
3.67 |
3.52 |
Gauze |
3.63 |
0.88 |
1.24 |
2.38 |
0.80 |
1.16 |
1.26 |
1.37 |
1.01 |
0.85 |
1.15 |
0.19 |
Chamber wash RF |
0.13 |
0.04 |
0.04 |
0.42 |
0.09 |
0.11 |
0.29 |
0.09 |
0.06 |
0.12 |
0.12 |
0.09 |
Total |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
100.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Absorption [%]a |
26.15 |
18.04 |
16.24 |
32.63 |
39.32 |
22.61 |
23.00 |
16.97 |
15.07 |
19.24 |
18.85 |
3.35 |
Recovery [%] normalized on applied dose |
87.99 |
96.59 |
97.30 |
87.19 |
89.62 |
94.81 |
94.95 |
94.79 |
94.33 |
94.51 |
95.11 |
1.09 |
% of total absorption at 12h |
49.33 |
37.37 |
48.68 |
1.06 |
44.21 |
61.83 |
61.72 |
97.14 |
93.39 |
45.03 |
67.96 |
22.23 |
In the total absorption (a) the amount of test item of skin, receptor fluid, gauze and chamber wash RF is included. In case of chamber 3, 6, 7 and 10 the strips 3 - ∞ were additionally included (b). The mean value for total absorption (c) is calculated of the total absorption values of the single replicates. Replicates 1, 2, 4 and 5 were excluded for evaluation of results (d). Mean is calculated from skin replicates 3, 6, 7, 8, 9 and 10(e).
Replicates 2 and 5 were excluded for evaluation of results due to a lack of receptor fluid. Replicates 1 and 4 were excludedbecause the recovery rates was outside the range of 100% ± 10%.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.